FAIRFIELD-SUISUN, CALIFORNIA
San Diego’s Carlsmed corrals $10 million to bring personalized medicine to spine surgeries [The San Diego Union-Tribune]
San Diego’s Carlsmed, which received regulatory approval last week for personalized implants used in complex spine surgeries, has raised $10 million in a Series A round of venture capital funding.
The 10-employee startup will use the money to further commercialize its “aprevo” implants for adult degenerative scoliosis. The condition results in curvature of the spine that can lead to lower back and leg pain, among other things. It affects about 6 million adults in the U.S.
Carlsmed has developed patented, machine learning technology that takes patient imaging, prior outcomes data and other information to design personalized implants for surgeries to straighten the spine, said Mike Cordonnier, chief executive and co-founder of Carlsmed.
Print
San Diego’s Carlsmed, which received regulatory clearance last week for personalized implants used in complex spine surgeries, has raised $10 million in a Series A round of venture capital funding.
The 10-employee startup will use the money to further commercialize its “aprevo” implants for adult degenerative scoliosis. The condition results in curvature of the spine that can lead to lower back and leg pain, among other things. It affects about 6 million adults in the U.S.
Carlsmed has developed patented, machine learning technology that takes patient imaging, prior outcomes data and other information to design personalized implants for surgeries to straighten the spine, said Mike Cordonnier, chief executive and co-founder of Carlsmed.